Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Wholesale: pleasing sales growth
Net sales (in million CHF)
2'728
761
■ Physicians
+3.8%
1'329
1'379
■ Pharmacies
Others
1'793
372
393
+5.7%
873
900
+3.0%
175
2021
84
87 +3.7%
H1 2021
H1 2022
1
Growth rate adjusted for one-off effect of a minor change in segment reporting
2
Impact of COVID-19 initiatives includes net sales of COVID-19 self-tests
08.08.2022
56
Key developments
Adjusted growth¹) in
physician segment
+8.4%
Growth in pharmacies
segment (without COVID-
19 Initiatives²))
+7.8%
Negative growth
impact of COVID-19
Initiatives²)
-3.1%
SARS-CoV-2 Rapid Antigon Test
253
SARS-CoV-2 Rapid Antigen Test
25
SARS-CoV-2 Rapid Antigen Test -
SARS-C-2 Rapid Antigen Test
GALENICAView entire presentation